Viagra (sildenafil) has helped millions of men with erectile dysfunction (ED). However, most people who use Viagra are not only on one drug, as they often have other health issues that require daily medications. Many already take five or more medicines every day, a situation known as polypharmacy.
From 1999 to 2018, polypharmacy in men increased by about 4.1% per year. This raises the risk of drug interactions, overlapping side effects, and complicated dosing schedules.
If you’re already on several medications, how do you know if adding Viagra is safe?
🔑 Key takeaways
|
How common is polypharmacy in men who use Viagra?
Data is limited in men who use Viagra specifically, but studies consistently show that polypharmacy is very common among men with ED. This is because men who seek treatment for ED often have underlying health conditions, including:
- Obesity
- Hypertension
- Type 2 diabetes
- High cholesterol
- Coronary artery disease
- Heart failure
- Benign prostatic hyperplasia (BPH)
- Depression or anxiety
One study reported that among men with ED, about 40% have hypertension, 42% have hyperlipidemia, and 20% have diabetes. Another study also found diabetes, hypertension, and dyslipidemia to be the most frequent comorbidities.
In some cases, patients have three or more comorbidities, each requiring medication. Research shows that 21% of hypertensive patients were exposed to polypharmacy.
A large population study also showed that the more medications a man takes, the more likely he is to report moderate ED.
- 0-2 meds: 15.9% of men reported moderate ED
- 3-5 meds: 19.7%
- 6-9 meds: 25.5%
- 10+ meds: 30.9%
This further increases the use of ED medications like Viagra.
How does polypharmacy affect how Viagra moves through the body?
Pharmacokinetic studies show that Viagra is absorbed fairly quickly. Peak blood levels usually appear about 1 hour after taking a tablet, though the range is around 30 minutes to 2 hours.
Only about 40% of the pill makes it into your bloodstream. The rest is lost as it moves through your digestive system. Once in circulation, your liver further processes it using two cytochrome P450 enzymes, mainly through CYP3A4 and partly through CYP2C9.
Any drug that boosts or blocks these enzymes can raise or lower Viagra levels. For someone who is taking multiple medications at once, this can become a real safety concern.
A hospital-based study examined 200 men with ED who were also taking medications for several other health conditions. The researchers identified 244 drug-related problems, with drug interactions being the most common problem.
Common side effects of Viagra and how other drugs can add to them
Clinical trial and product label data show the most frequent side effects of Viagra include:
- Headache
- Flushing or warmth
- Indigestion or heartburn
- Back pain and muscle pain
- Nasal congestion
- Dizziness
Less common but serious events include:
- Priapism (prolonged painful erection lasting more than 4 hours)
- Sudden loss of vision, sometimes linked to non-arteritic anterior ischemic optic neuropathy (NAION)
- Sudden hearing loss or significant decrease in hearing, sometimes with tinnitus or dizziness
- Severe hypotension in certain drug combinations
In people who already take drugs that affect vision or hearing, these events are harder to interpret. It can also be harder to notice which medicine is responsible, which is why polypharmacy and Viagra use must be considered together.
Which drug combinations should you watch out for?
Some combinations are not absolute prohibitions in every guideline, but they are risky enough to require dose adjustment, timing changes, or extra monitoring.
- Alpha-blockers
Alpha-blockers and Viagra both lower blood pressure. When combined, the fall in pressure can be more pronounced and can cause dizziness, fainting, or falls.
Examples of alpha-blockers include:
- Terazosin (Hytrin®)
- Tamsulosin (Flomax®)
- Doxazosin (Cardura®)
- Prazosin (Minipress®)
- Alfuzosin (Uroxatral®)
- Silodosin (Rapaflo®)
This interaction is very common in practice because many men with ED also have BPH and are already on tamsulosin or a similar drug.
A study looked at men who were already taking doxazosin for at least 8 weeks. Here’s what they found:
- 4 mg doxazosin + 50 mg sildenafil: 2 out of 20 men had low blood pressure symptoms
- 4 mg doxazosin + 100 mg sildenafil: 0 out of 20 men had symptoms
- 4 mg doxazosin + 25 mg sildenafil: No cases of low blood pressure
If you’re already stable on an alpha-blocker, Viagra should be started at the lowest dose. If you’re already taking Viagra regularly, your alpha-blocker should be started at the lowest dose and increased slowly if needed.
- Other antihypertensive drugs
Polypharmacy is about five times more common in people with hypertension.
Among people with hypertension who had polypharmacy, 76% had type C drug interactions, which require monitoring or dose adjustments but are not immediately dangerous.
In people already taking multiple antihypertensive drugs, including:
- ACE inhibitors
- ARBs
- Beta blockers
- Calcium channel blockers
- Diuretics
The blood-pressure-lowering effect can add up. Research shows that Viagra only lowers blood pressure by about 6 mmHg systolic and 4.5 mmHg diastolic. A few had bigger drops, but none of them developed symptoms of hypotension, and the medication was overall well-tolerated.
- Strong CYP3A4 inhibitors
As mentioned earlier, Viagra is mainly broken down by CYP3A4 in the liver. When strong inhibitors of this enzyme are present, sildenafil stays in the body much longer and at much higher levels, increasing the risk of side effects.
These include:
- Protease inhibitors such as ritonavir (Norvir®), indinavir (Crixivan®), saquinavir (Fortovase® or Invirase®), or atazanavir (Reyataz®)
- Azole antifungals such as ketoconazole (Nizoral®) or itraconazole (Sporanox®)
- Macrolide antibiotics such as clarithromycin (Biaxin®), telithromycin (Ketek®), or erythromycin
In clinical trials, ritonavir increased sildenafil exposure by 11-fold. Saquinavir increased sildenafil peak levels by 140% and overall exposure by 210%. Erythromycin increased sildenafil peak levels by 160% and total exposure by 182%. Other strong inhibitors, such as ketoconazole and itraconazole, are expected to raise sildenafil levels even more.
Although these medications are not commonly part of typical long-term polypharmacy regimens, they can increase the likelihood of rare events like visual changes or priapism.
For anyone taking strong CYP3A4 inhibitors, the recommended starting dose of Viagra is 25 mg. Those taking ritonavir should not take more than 25 mg of Viagra within 48 hours.
- CYP3A4 inducers
Drugs that boost CYP3A4 enzymes, such as rifampin, carbamazepine, bosentan, and some anticonvulsants, can have the opposite effect. They clear sildenafil more quickly, which lowers its blood level. This may reduce Viagra’s benefit, so the usual dose may feel less effective.
A study in healthy men showed that sildenafil’s overall exposure dropped by 63% when taken together with bosentan. Its peak level in the blood also dropped by 55%. Stronger inducers, like rifampin, are expected to reduce sildenafil levels even more.
However, you shouldn’t simply increase your dose without guidance, because inducers can be stopped or changed, at which point Viagra exposure would suddenly rise again.
- Non-prescription drugs, supplements, and recreational substances
Polypharmacy is not only about prescription drugs. Many Viagra interactions come from products that patients don’t always realize can affect their medication.
Over-the-counter medicines
Common OTC products that matter include:
- Decongestants containing pseudoephedrine or phenylephrine, which can raise systolic blood pressure and heart rate.
- NSAIDs such as ibuprofen, which can reduce kidney blood flow and may worsen kidney function, particularly in people with chronic kidney disease or borderline renal function.
Although these don’t interact with Viagra directly, they can still affect overall risk in someone already taking multiple medications. A study of older home-care patients, where 43% were taking 5 or more medications, found that among 11 people using OTC ibuprofen, 9 had a potential drug interaction.
Herbal and dietary supplements
Some herbal products induce or inhibit CYP enzymes. St John’s wort is a known CYP3A4 inducer and can reduce sildenafil levels.
Grapefruit juice can inhibit CYP3A4 in the gut wall and increase sildenafil exposure. In one study, it increased the total amount of sildenafil absorbed in the body by about 23% and delayed the time it took to reach peak levels by about 15 minutes. It’s best to avoid drinking grapefruit juice when taking Viagra.
In addition, many “herbal” or “all-natural” sexual enhancement supplements secretly contain real prescription ED drugs like sildenafil and tadalafil.
Researchers bought sexual enhancement supplements from retail stores in Sacramento, California, and laboratory results showed that two-thirds of the products were secretly adulterated. Among the contaminated products:
- 40% contained one PDE5 inhibitor
- 60% contained two or more (dangerous combinations)
They also found that sildenafil was the most common adulterant.
This can add hidden doses on top of prescribed Viagra, which increases the risk of side effects and interactions. Back in 2002, a fatal case of Viagra overdosage happened to a 56-year-old male who also had a history of diabetes, hypertension, chronic alcoholism, anxiety-depressive disorders, and ED.
What drugs should never be taken with Viagra?
Below are combinations that guidelines and product labels say to avoid completely.
- Organic nitrates
Viagra should not be taken if you’re on regular nitrate therapy for chronic angina. These include:
- Nitroglycerin (also available in sublingual tablets, sublingual spray, transdermal patch, and ointment)
- Isosorbide dinitrate (ISDN)
- Isosorbide mononitrate (ISMN)
Organic nitrates increase nitric oxide, which raises cGMP. It’s a chemical messenger inside the cells that helps relax and widen blood vessels, improving blood flow.
At the same time, Viagra stops cGMP from breaking down because it is what allows blood to fill the erectile tissue and create an erection.
When both are taken together, cGMP builds up too much, causing a sharp drop in blood pressure. This can lead to fainting, a heart attack, or even death.
Research shows that men who used both nitrates and a PDE5 inhibitor had a 72% higher risk of heart attack, and a 39% higher overall mortality risk. In 2000, 16 deaths were reported in people who took sildenafil together with organic nitrates.
- Riociguat and other soluble guanylate cyclase stimulators
Riociguat is used for certain types of pulmonary hypertension. It also increases cGMP in the cardiovascular system even without nitric oxide.
If you have pulmonary hypertension and take drugs like riociguat, you should not use Viagra unless your specialist clearly directs an alternative regimen.
Who needs extra caution when using Viagra?
Viagra’s safety and dosing can change in some populations, such as those with organ impairment or those with heavy medication use. They may need lower doses, closer monitoring, or, in some cases, avoidance.
- Older adults
Older adults are more likely to take multiple medications and have age-related changes in liver function, kidney function, and blood pressure control.
These factors alter how the body handles sildenafil. Studies show higher sildenafil exposure in adults over 65, so lower starting doses are recommended, especially when other drugs are involved.
- Liver problems
Because Viagra is highly dependent on liver metabolism, severe hepatic impairment is usually considered a strong caution or a reason to avoid use.
In mild to moderate liver disease, sildenafil levels can rise significantly, about 50% higher at peak and nearly double overall. So the recommended starting dose is 25 mg for anyone with hepatic impairment.
Many people with chronic liver disease are also on multiple medicines, such as diuretics, beta blockers, lactulose, or anticoagulants. This combination of polypharmacy and slower drug clearance can increase the risk of side effects.
- Kidney disease
No dose change is needed for people with mild or moderate kidney impairment. But in severe kidney disease (creatinine clearance <30 mL/min), sildenafil is cleared more slowly, causing drug levels to rise to about twice the normal amount. For this reason, patients with severe renal impairment are also advised to start with the 25 mg dose.
People with kidney disease often take multiple medications as well, including blood pressure drugs, phosphate binders, vitamin D analogs, and diabetes treatments. In this setting, any additional drop in blood pressure or fainting episode can be dangerous.
- Sensory concerns in higher-risk patients
Viagra can cause temporary visual changes such as blue-tinted vision or increased sensitivity to light. These are thought to arise from some effect on PDE6 in the retina. They usually resolve after the drug is cleared.
In rare cases, sudden vision loss due to NAION has been reported in users of PDE5 inhibitors. Although a direct cause has not been fully proven, regulatory agencies advise that patients who experience a sudden loss of vision in one or both eyes stop the drug and seek urgent medical care.
Age, vascular disease, smoking, and certain eye anatomy features are known risk factors for NAION. Many men with ED already have vascular disease and may be taking several cardiovascular drugs, antiplatelet agents, and lipid-lowering agents. That combination makes it harder to know whether vision changes relate mostly to the disease background, the polypharmacy, or Viagra itself.
Hearing issues have also been reported. Post-marketing data and some observational studies suggest that PDE5 inhibitors may, in rare cases, be linked to sudden hearing loss.
Older men, in particular, often already have age-related hearing decline or may use other medicines that can harm hearing, such as loop diuretics or some antibiotics. Polypharmacy again complicates the situation.
How to safely use Viagra when you’re on polypharmacy
Here are practical steps to reduce the risk of dangerous drug interactions:
Bring an accurate and complete medication list
Write down every product you use:
- All prescription drugs, with doses and how often you take them
- Over-the-counter medicines, including occasional ones such as cold remedies or pain relievers
- Vitamins, herbal remedies, and supplements
- Recreational substances
Bring this list to your doctor or pharmacist and update it whenever something changes. Most interaction issues are identified only when all medications are evaluated as a whole.
Ask specific questions
When talking about Viagra, questions like these can help:
- “I have nitroglycerin for chest pain. Does that mean Viagra is unsafe for me?”
- “I am on tamsulosin and two blood pressure drugs. How will we reduce the risk of low blood pressure?”
- “My HIV medicines include ritonavir. How does that affect the dose of Viagra?”
- “How far apart should I space Viagra from my blood pressure medications?”
- “Does alcohol change how Viagra works for me?”
- “Am I at higher risk for vision or hearing side effects because of my health conditions?”
These questions help your clinician spot interaction risks right away and ensure your treatment plan is as safe as possible.
Start low and monitor symptoms
A 25 mg starting dose is recommended for older adults and for patients with liver or kidney impairment.
Monitor for:
- Lightheadedness, especially when standing up
- Chest pain or unusual shortness of breath
- Sudden change in vision or hearing
- Painful erection that lasts more than 4 hours
Report these to your doctor immediately or seek emergency care, depending on severity.
Avoid unsupervised dose stacking
Some people are tempted to take more Viagra if the first dose does not work as well as hoped. This can be dangerous in a polypharmacy setting. Lack of effect may arise from poor timing with meals, anxiety, or underlying vascular disease, not only from “too low a dose”.
Adding extra tablets on your own can raise pressure on your cardiovascular system and increase the chance of serious side effects.
If treatment seems ineffective, schedule a follow-up visit with your doctor. They can adjust your dose, check for endocrine or vascular conditions, or even switch to a different PDE5 inhibitor when appropriate.
Final thoughts
Viagra and polypharmacy often overlap because many men with ED also manage hypertension, diabetes, high cholesterol, or heart disease. Multiple medications can change how Viagra is absorbed, increase side effects, or create risky combinations such as nitrates, alpha-blockers, and strong CYP3A4 inhibitors.
To use Viagra safely when you take many medicines, keep an updated medication list and avoid adjusting doses on your own. Always confirm with your clinician whether your current medication regimen is truly safe.
Frequently Asked Questions
Can Viagra interfere with medications used for depression or anxiety?
Viagra usually does not have direct interactions with most antidepressants or anxiolytics. However, some SSRIs and SNRIs can cause sexual dysfunction on their own, which may affect how well Viagra seems to work. Tricyclic antidepressants and MAOIs can sometimes influence blood pressure, so if you’re on these medicines, monitor for dizziness when Viagra is added.
Is Viagra safe for someone who uses aspirin?
In human studies, Viagra did not increase bleeding time on its own or when taken with aspirin. Lab studies, however, show that sildenafil can strengthen the blood-thinning effect of nitric-oxide-donor drugs, and animal studies suggest a possible additive effect with heparin. But these findings have not been confirmed in humans. The safety of Viagra in people with bleeding disorders or active stomach ulcers is not known.
Does Viagra interact with thyroid medications such as levothyroxine?
There is no known interaction between Viagra and thyroid hormone replacement. People with uncontrolled hyperthyroidism or hypothyroidism may experience changes in heart rhythm or blood pressure, which should be stabilized before any ED treatment is started.
Sources
- Varghese, D., Ishida, C., Patel, P., & Koya, H. H. (2024, February 12). Polypharmacy. StatPearls – NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK532953/
- Wang, X., Liu, K., Shirai, K., Tang, C., Hu, Y., Wang, Y., Hao, Y., & Dong, J. Y. (2023). Prevalence and trends of polypharmacy in U.S. adults, 1999-2018. Global health research and policy, 8(1), 25. https://doi.org/10.1186/s41256-023-00311-4
- Li, J. Z., Maguire, T. A., Zou, K. H., Lee, L. J., Donde, S. S., & Taylor, D. G. (2022). Prevalence, Comorbidities, and Risk Factors of Erectile Dysfunction: Results from a Prospective Real-World Study in the United Kingdom. International journal of clinical practice, 2022, 5229702. https://doi.org/10.1155/2022/5229702
- Bogari, M., Alzahrani, B. A., Aghashami, A. S., Alsubeay, A. M. S., Hassan, F., Ahmed, M. E., & Almuqati, M. M. (2023). Male Sexual Dysfunction-Related medical comorbidities in a tertiary care Center, Western region, Saudi Arabia. Cureus, 15(7), e41732. https://doi.org/10.7759/cureus.41732
- Alsanosi, S. M., Mousa, A. H., Ahmadini, H. A., Qadhi, R. S., Ikram, N., Felemban, A. H., Alqashqri, H. S., Hariri, N. H., Alhindi, Y. Z., & Ayoub, N. (2023). Polypharmacy among patients with hypertension attending primary healthcare centres. Annals of medicine and surgery (2012), 85(6), 2545–2549. https://doi.org/10.1097/MS9.0000000000000818
- Londoño, D. C., Slezak, J. M., Quinn, V. P., Van Den Eeden, S. K., Loo, R. K., & Jacobsen, S. J. (2011). Population‐based study of erectile dysfunction and polypharmacy. British Journal of Urology, 110(2), 254–259. https://doi.org/10.1111/j.1464-410x.2011.10761.x
- Murtadha, M., Raslan, M. A., Fahmy, S. F., & Sabri, N. A. (2021). Changes in the Pharmacokinetics and Pharmacodynamics of Sildenafil in Cigarette and Cannabis Smokers. Pharmaceutics, 13(6), 876. https://doi.org/10.3390/pharmaceutics13060876
- Huri, H. Z., Ling, C. F., & Razack, A. H. A. (2017). Drug-related problems in patients with erectile dysfunctions and multiple comorbidities. Therapeutics and Clinical Risk Management, Volume 13, 407–419. https://doi.org/10.2147/tcrm.s118010
- Zare, P., Poustchi, H., Mohammadi, Z., Mesgarpour, B., Akbari, M., Kamalipour, A., Abdipour-Mehrian, S. R., Hashemi, E., Ghamar-Shooshtari, A., Hosseini, S. A., Malekzadeh, R., Drissi, H. B., Malekzadeh, F., & Vardanjani, H. M. (2024). Polypharmacy and medication usage patterns in hypertensive patients: Findings from the Pars Cohort Study. Research in Social and Administrative Pharmacy, 20(11), 1038–1046. https://doi.org/10.1016/j.sapharm.2024.07.006
- Kloner, R. A. (2004). Cardiovascular effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction. Circulation, 110(19), 3149–3155. https://doi.org/10.1161/01.cir.0000146906.42375.d3
- Vardi, Y., Klein, L., Nassar, S., Sprecher, E., & Gruenwald, I. (2002). Effects of sildenafil citrate (viagra) on blood pressure in normotensive and hypertensive men. Urology, 59(5), 747–752. https://doi.org/10.1016/s0090-4295(02)01510-8
- Hermann, M., Carstens, N., Kvinge, L., Fjell, A., Wennersberg, M., Folleso, K., Skaug, K., Seiger, A., Cronfalk, B. S., & Bostrom, A. M. (2021). Polypharmacy and Potential Drug-Drug Interactions in Home-Dwelling Older People – A Cross-Sectional Study. Journal of multidisciplinary healthcare, 14, 589–597. https://doi.org/10.2147/JMDH.S297423
- Fischer, T., Tucker, J., Li, C., Min, K., Xu, D., Upjohn, L., & Kumar, M. (2023). Cross-Sectional survey of adulterated sexual enhancement products sold in the Sacramento area of California. Nutrition and Dietary Supplements, Volume 15, 111–120. https://doi.org/10.2147/nds.s409032
- Tracqui, A., Miras, A., Tabib, A., Raul, J. S., Ludes, B., & Malicier, D. (2002). Fatal overdosage with sildenafil citrate (Viagra1): first report and review of the literature. Human & Experimental Toxicology, 21(11), 623–629. https://doi.org/10.1191/0960327102ht302oa
- Lagerros, Y. T., Grotta, A., Freyland, S., Grannas, D., & Andersson, D. P. (2024). Risk of death in patients with coronary artery disease taking nitrates and phosphodiesterase-5 inhibitors. Journal of the American College of Cardiology, 83(3), 417–426. https://doi.org/10.1016/j.jacc.2023.10.041
- Jetter, A., Kinzig‐Schippers, M., Walchner‐Bonjean, M., Hering, U., Bulitta, J., Schreiner, P., Sörgel, F., & Fuhr, U. (2002). Effects of grapefruit juice on the pharmacokinetics of sildenafil. Clinical Pharmacology & Therapeutics, 71(1), 21–29. https://doi.org/10.1067/mcp.2002.121236
- Ausó, E., Gómez-Vicente, V., & Esquiva, G. (2021). Visual Side Effects Linked to Sildenafil Consumption: An Update. Biomedicines, 9(3), 291. https://doi.org/10.3390/biomedicines9030291
- VIAGRA® (sildenafil citrate) tablets. (n.d.). https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=d905dc8d-917f-4ea3-a4ee-a1ecf6967d4e&type=display#ID_05f2cc85-6f1a-4aac-8958-7020141b4d26
Author Bio: Dr. Adrian Blackwell is the founder and CEO of PonteVita Rx, a telehealth practice dedicated to making medication access simpler, more affordable, and less stressful. Licensed to practice medicine in all 50 states and DC, Dr. Blackwell is board certified in obesity medicine and emergency medicine. He combines clinical expertise with personal experience navigating the healthcare system as a patient and parent to children with chronic illnesses. His mission: ensure everyone has access to their necessary medications without unnecessary barriers.
Medical Disclaimer: All the information here, on these videos, YouTube, social media, or in any other format, is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult your personal physician or other qualified health provider with any questions you may have regarding a medical condition. Never replace professional medical advice given to you personally or delay in seeking it because of something you have read or heard on this website. This information is not meant to diagnose, treat, or cure any medical condition. No patient-physician relationship is formed. If you’re my patient, please text me before you make any changes to your medication. If you believe you are having a medical emergency please call 911.